Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis

Published:2016-09-02 Issue:1 Volume:16 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Bundhun Pravesh Kumar,Janoo Girish,Teeluck Abhishek Rishikesh,Huang Wei-Qiang

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12872-016-0347-7.pdf

Reference19 articles.

1. Bhatt DL. Intensifying platelet inhibition--navigating between Scylla and charybdis. N Engl J Med. 2007;357(20):2078–81.

2. Levine GN, Bates ER, Blankenship JC, et al. American college of cardiology foundation; American heart association task force on PracticeGuidelines; society for cardiovascular angiography and interventions. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American college ofCardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol. 2011;58(24):e44–122. doi: 10.1016/j.jacc.2011.08.007 .

3. Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularizationof the European society of cardiology (ESC) and the European association for cardio-thoracic surgery(EACTS)developed with the special contribution of the European association of percutaneous CardiovascularInterventions (EAPCI). Eur Heart J. 2014;35(37):2541–619. doi: 10.1093/eurheartj/ehu278 .

4. Peters RJ, Mehta SR, Fox KA, et al. Clopidogrel in unstable angina to preventRecurrent events (CURE) trial investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation. 2003;108:1682–7.

5. King 3rd SB, Smith Jr SC, Hirshfeld Jr JW, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: are port of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol. 2008;51(2):172–209.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database;Frontiers in Pharmacology;2024-09-13

2. Platelet Function Tests Predicting the Efficacy and Safety of Aspirin Secondary Prevention;Neurological Research;2021-09-28

3. Low-Dose Aspirin Is Adequate for Venous Thromboembolism Prevention Following Total Joint Arthroplasty: A Systematic Review;The Journal of Arthroplasty;2020-03

4. Aspirin antiplatelet effects are associated with body weight;Vascular Pharmacology;2020-02

5. Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis;Advances in Therapy;2019-06-01